ALLMedicine™ Autoimmune Gastrointestinal Dysmotility Center
Research & Reviews 9 results
https://doi.org/10.1111/nmo.13256
Neurogastroenterology and Motility : the Official Journal... Ashat M, Lewis A et. al.
Dec 5th, 2017 - Gastroparesis is a complex clinical entity; many aspects of which remain unknown. Although most patients have idiopathic, diabetic, or postsurgical gastroparesis, many are thought to have measurable neuromuscular abnormalities. Immunotherapy has r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623317
BMJ Case Reports; Lipowska AM, Micic D et. al.
Aug 12th, 2017 - The diagnosis of autoimmune gastrointestinal dysmotility requires a high level of clinical suspicion when standard work-up is unrevealing. We report the case of a 56-year-old male patient with history of tobacco use and a subacute presentation of ...
https://rarediseases.info.nih.gov/diseases/12063/autoimmune-gastrointestinal-dysmotility
Jul 26th, 2017 - Autoimmune gastrointestinal dysmotility (AGID) is a type of dysautonomia that may be idiopathic (cause unknown) or associated with cancer elsewhere in the body, most commonly small cell lung cancer.[1] Signs and symptoms may include early satiety ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149849
Neurogastroenterology and Motility : the Official Journal... Flanagan EP, Saito YA et. al.
Jul 21st, 2014 - Chronic gastrointestinal dysmotility greatly impacts the quality of life. Treatment options are limited and generally symptomatic. Neural autoimmunity is an under-recognized etiology. We evaluated immunotherapy as an aid to diagnosing autoimmune g...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535544
Neurogastroenterology and Motility : the Official Journal... Meeusen JW, Haselkorn KE et. al.
Oct 17th, 2012 - Autoimmune gastrointestinal dysmotility (AGID) is a limited form of dysautonomia. The only proven effector to date is IgG specific for ganglionic nicotinic-acetylcholine receptors containing α3 subunits [α3*- nicotinic acetylcholine receptor (nACh...
Clinicaltrials.gov 9 results
https://doi.org/10.1111/nmo.13256
Neurogastroenterology and Motility : the Official Journal... Ashat M, Lewis A et. al.
Dec 5th, 2017 - Gastroparesis is a complex clinical entity; many aspects of which remain unknown. Although most patients have idiopathic, diabetic, or postsurgical gastroparesis, many are thought to have measurable neuromuscular abnormalities. Immunotherapy has r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623317
BMJ Case Reports; Lipowska AM, Micic D et. al.
Aug 12th, 2017 - The diagnosis of autoimmune gastrointestinal dysmotility requires a high level of clinical suspicion when standard work-up is unrevealing. We report the case of a 56-year-old male patient with history of tobacco use and a subacute presentation of ...
https://rarediseases.info.nih.gov/diseases/12063/autoimmune-gastrointestinal-dysmotility
Jul 26th, 2017 - Autoimmune gastrointestinal dysmotility (AGID) is a type of dysautonomia that may be idiopathic (cause unknown) or associated with cancer elsewhere in the body, most commonly small cell lung cancer.[1] Signs and symptoms may include early satiety ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149849
Neurogastroenterology and Motility : the Official Journal... Flanagan EP, Saito YA et. al.
Jul 21st, 2014 - Chronic gastrointestinal dysmotility greatly impacts the quality of life. Treatment options are limited and generally symptomatic. Neural autoimmunity is an under-recognized etiology. We evaluated immunotherapy as an aid to diagnosing autoimmune g...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535544
Neurogastroenterology and Motility : the Official Journal... Meeusen JW, Haselkorn KE et. al.
Oct 17th, 2012 - Autoimmune gastrointestinal dysmotility (AGID) is a limited form of dysautonomia. The only proven effector to date is IgG specific for ganglionic nicotinic-acetylcholine receptors containing α3 subunits [α3*- nicotinic acetylcholine receptor (nACh...